2,2-bis(bromomethyl)-1,3-propanediol has been researched along with Colonic Neoplasms in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bisetti, N; Bornet, F; Bouhnik, Y; FlouriƩ, B; Gailing, MF; Guibert, A; Rambaud, JC; Riottot, M | 1 |
1 trial(s) available for 2,2-bis(bromomethyl)-1,3-propanediol and Colonic Neoplasms
Article | Year |
---|---|
Effects of fructo-oligosaccharides ingestion on fecal bifidobacteria and selected metabolic indexes of colon carcinogenesis in healthy humans.
Topics: Adult; beta-Fructofuranosidase; Bifidobacterium; Bile Acids and Salts; Colonic Neoplasms; Feces; Female; Fructose; Glucuronidase; Glycoside Hydrolases; Humans; Hydrogen-Ion Concentration; Male; NADH, NADPH Oxidoreductases; Nitroreductases; Oligosaccharides; Placebos; Sterols | 1996 |